ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,447Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 23

$607K Total Retail Price of All Prescriptions

Rank: 2 out of 23

485 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 485 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

5% of this provider’s 485 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 11,143 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LISINOPRIL 715 638 1 1
PRAVASTATIN SODIUM 648 596 2 12
OMEPRAZOLE 641 570 3 5
FELODIPINE ER 622 592 10 4 18
LOSARTAN POTASSIUM 545 497 5 6
SIMVASTATIN 450 392 6 2
GLIPIZIDE ER 423 408 7 22
METFORMIN HCL 414 358 8 7
HYDROCHLOROTHIAZIDE 403 394 9 16
LEVOTHYROXINE SODIUM 341 309 10 9
LOVASTATIN 333 304 11 10
ATORVASTATIN CALCIUM 239 220 12 8
CARVEDILOL 196 184 13 34
ALENDRONATE SODIUM 191 191 14 17
GLIPIZIDE 182 159 15 45
AZITHROMYCIN 180 156 16 43
TERAZOSIN HCL 178 176 17 67
AMLODIPINE BESYLATE 175 157 18 4
FUROSEMIDE 161 146 19 13
POTASSIUM CHLORIDE 161 127 19 41
PREDNISONE 143 121 21 39
ALLOPURINOL 135 135 22 14
LOSARTAN-HYDROCHLOROTHIAZIDE 133 123 23 19
JANUVIA 123 123 24 56
METOPROLOL SUCCINATE 123 98 24 15
TAMSULOSIN HCL 107 107 26 31
NIFEDIPINE ER 104 95 27 56
AMLODIPINE BESYLATE-BENAZEPRIL 103 103 28 41
METOPROLOL TARTRATE 99 67 29 21
IBUPROFEN 97 79 30 38
GEMFIBROZIL 93 75 31 94
MECLIZINE HCL 91 90 32 37
ATENOLOL 91 85 32 26
KLOR-CON 10 88 86 34 96
PANTOPRAZOLE SODIUM 86 86 35 32
NEXIUM 82 79 36 59
DILTIAZEM 24HR ER 79 64 37 99
DIOVAN 75 70 38 30
ZETIA 72 72 39 81
GABAPENTIN 72 58 39 27
CLONIDINE HCL 69 63 41 74
RANITIDINE HCL 65 54 42 33
COLCRYS 64 47 43 44
FINASTERIDE 61 61 44 116
CLOPIDOGREL 60 55 45 35
PROAIR HFA 59 49 46 40
PROPRANOLOL HCL 53 40 47 128
HYDROCODONE-ACETAMINOPHEN 53 35 S3 47 3
LANTUS SOLOSTAR 51 41 49 89
LANTUS 50 20 50 135
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 29, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.